Articles

Novo Nordisk data presented last week, showed that when taken by itself, once-daily liraglutide, an investigational treatment for Type 2 diabetes, leads to statistically significant and sustained reductions in blood sugar and weight in African Americans with Type 2 diabetes, as compared to glimepiride.

Scientists have identified a master regulator gene for early embryonic development of the pancreas and other organs, putting researchers closer to coaxing stem cells into pancreatic cells as a possible cure for Type 1 diabetes.

A cellular protein that may prevent nerve cells from dying also helps to improve insulin action and lower blood glucose levels, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University.

Lead investigator Sheri R. Colberg, found that 1 hour of aerobic exercise has a minimal impact on plasma glucose level when performed in fasted moderately hyperglycemic Type 2 diabetic men, but induces an important decrease in plasma glucose level when performed 2 hours after the meal.

A heightened level of a certain growth factor in the blood may explain why blacks have a greater prevalence of hypertension and kidney disease compared to whites.

A newly published study, showed that a flavonoid derived from citrus fruit has tremendous promise for preventing weight gain and other signs of metabolic syndrome which can lead to Type 2 diabetes and increased risk of cardiovascular disease.

Although people with diabetes have a higher risk of being diagnosed with depression than other people, a large, new study has found that much of that increase can be accounted for by their more frequent contacts with the medical system, rather than the diabetes itself.

Early data from a phase 2 dose-ranging study with aleglitazar (Hoffman-La Roche, Switzerland), a dual peroxisome proliferator-activated receptor (PPAR) agonist, has shown the drug to be safe and effective in the treatment of Type 2 diabetes.

Customized feedback via customized patient mailings to patients and their physicians does not lead to improved safety and quality of diabetes care, according to a new report in Diabetes Care.

According to the results of a retrospective cohort study, in diabetic patients hospitalized in the general ward, hypoglycemia is common and is associated with an increased length of stay (LOS) and higher mortality rate.